Transcranial Magnetic Stimulation for MCI

🩺 Protocol Summary

The goal of this phase II study is to establish the dose-response curves of a safe and clinically feasible non-invasive brain stimulation technique (accelerated Transcranial Magnetic Stimulation (TMS)) to improve both depression and cognitive function in Mild Cognitive Impairment (MCI) patients with comorbid depression. It is known that TMS can effectively treat depression. Identifying the right dose of accelerated TMS in MCI patients is necessary prior to designing subsequent trials to determine efficacy. These results will inform future clinical trials of accelerated TMS for MCI, with the long-term goal of developing an efficacious treatment to prevent dementia.

Primary Research Facility: Medical University of South Carolina (Charleston, South Carolina)

Review these 3 basic logistical and protocol criteria extracted from the public NIH record. (This is a preliminary logistical checklist, not an official clinical eligibility determination).

Diagnosed with, undergoing evaluation for, or seeking treatment related to Mild Cognitive Impairment?

🔍 Study Population / Focus Area (Source: Protocol Primary Condition)

Aged between 60 Years and 85 Years?

🔍 Protocol Specified Age Range: 60 Years to 85 Years

Able to attend required clinic visits at Medical University of South Carolina (Charleston, South Carolina)?

🔍 Logistical Requirement: Site at Medical University of South Carolina

📍 Primary Site Map

Site: Medical University of South Carolina — Charleston, South Carolina

💰 Clinical Trial Costs & Insurance Coverage

Coverage for clinical trial participation varies depending on your health insurance policy, state legislation, and whether specific procedures are investigational research or routine medical care. Under federal law (Affordable Care Act § 2709), health insurers generally cannot drop coverage or refuse to pay for routine patient care costs incurred in approved clinical trials.

💡 Always ask the study coordinator for the trial's official Informed Consent Form, which outlines all sponsor-funded research items versus procedures billed to your insurance.